We've found
1,179
archived clinical trials in
Anxiety
We've found
1,179
archived clinical trials in
Anxiety
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Updated: 3/27/2013
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Tolerability of SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP).
Status: Enrolling
Updated: 3/27/2013
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Updated: 3/27/2013
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Tolerability of SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP).
Status: Enrolling
Updated: 3/27/2013
Click here to add this to my saved trials
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Updated: 3/27/2013
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Tolerability of SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP).
Status: Enrolling
Updated: 3/27/2013
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Updated: 3/27/2013
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Tolerability of SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP).
Status: Enrolling
Updated: 3/27/2013
Click here to add this to my saved trials
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Updated: 3/27/2013
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Tolerability of SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP).
Status: Enrolling
Updated: 3/27/2013
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Updated: 3/27/2013
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Tolerability of SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP).
Status: Enrolling
Updated: 3/27/2013
Click here to add this to my saved trials
Efficacy of Massage Therapy in the Treatment of Generalized Anxiety Disorder (GAD)
Updated: 4/2/2013
Efficacy of Massage and Light Touch Therapy for the Treatment of Generalized Anxiety Disorder
Status: Enrolling
Updated: 4/2/2013
Efficacy of Massage Therapy in the Treatment of Generalized Anxiety Disorder (GAD)
Updated: 4/2/2013
Efficacy of Massage and Light Touch Therapy for the Treatment of Generalized Anxiety Disorder
Status: Enrolling
Updated: 4/2/2013
Click here to add this to my saved trials
Assessment of Sexual Dysfunction, Depression and Anxiety in Underserved, Minority Gynecologic Cancers Patients
Updated: 4/26/2013
Assessment of the Prevalence of Sexual Dysfunction, Depression, and Anxiety in Underserved and Minority Patients With Gynecologic Cancers
Status: Enrolling
Updated: 4/26/2013
Assessment of Sexual Dysfunction, Depression and Anxiety in Underserved, Minority Gynecologic Cancers Patients
Updated: 4/26/2013
Assessment of the Prevalence of Sexual Dysfunction, Depression, and Anxiety in Underserved and Minority Patients With Gynecologic Cancers
Status: Enrolling
Updated: 4/26/2013
Click here to add this to my saved trials
Assessment of Sexual Dysfunction, Depression and Anxiety in Underserved, Minority Gynecologic Cancers Patients
Updated: 4/26/2013
Assessment of the Prevalence of Sexual Dysfunction, Depression, and Anxiety in Underserved and Minority Patients With Gynecologic Cancers
Status: Enrolling
Updated: 4/26/2013
Assessment of Sexual Dysfunction, Depression and Anxiety in Underserved, Minority Gynecologic Cancers Patients
Updated: 4/26/2013
Assessment of the Prevalence of Sexual Dysfunction, Depression, and Anxiety in Underserved and Minority Patients With Gynecologic Cancers
Status: Enrolling
Updated: 4/26/2013
Click here to add this to my saved trials
ICU Family Communication Study
Updated: 6/25/2013
A Randomized Trial of an Interdisciplinary Communication Intervention to Improve Patient and Family Outcomes in the Intensive Care Unit
Status: Enrolling
Updated: 6/25/2013
ICU Family Communication Study
Updated: 6/25/2013
A Randomized Trial of an Interdisciplinary Communication Intervention to Improve Patient and Family Outcomes in the Intensive Care Unit
Status: Enrolling
Updated: 6/25/2013
Click here to add this to my saved trials
ICU Family Communication Study
Updated: 6/25/2013
A Randomized Trial of an Interdisciplinary Communication Intervention to Improve Patient and Family Outcomes in the Intensive Care Unit
Status: Enrolling
Updated: 6/25/2013
ICU Family Communication Study
Updated: 6/25/2013
A Randomized Trial of an Interdisciplinary Communication Intervention to Improve Patient and Family Outcomes in the Intensive Care Unit
Status: Enrolling
Updated: 6/25/2013
Click here to add this to my saved trials
ICU Family Communication Study
Updated: 6/25/2013
A Randomized Trial of an Interdisciplinary Communication Intervention to Improve Patient and Family Outcomes in the Intensive Care Unit
Status: Enrolling
Updated: 6/25/2013
ICU Family Communication Study
Updated: 6/25/2013
A Randomized Trial of an Interdisciplinary Communication Intervention to Improve Patient and Family Outcomes in the Intensive Care Unit
Status: Enrolling
Updated: 6/25/2013
Click here to add this to my saved trials
ICU Family Communication Study
Updated: 6/25/2013
A Randomized Trial of an Interdisciplinary Communication Intervention to Improve Patient and Family Outcomes in the Intensive Care Unit
Status: Enrolling
Updated: 6/25/2013
ICU Family Communication Study
Updated: 6/25/2013
A Randomized Trial of an Interdisciplinary Communication Intervention to Improve Patient and Family Outcomes in the Intensive Care Unit
Status: Enrolling
Updated: 6/25/2013
Click here to add this to my saved trials
ICU Family Communication Study
Updated: 6/25/2013
A Randomized Trial of an Interdisciplinary Communication Intervention to Improve Patient and Family Outcomes in the Intensive Care Unit
Status: Enrolling
Updated: 6/25/2013
ICU Family Communication Study
Updated: 6/25/2013
A Randomized Trial of an Interdisciplinary Communication Intervention to Improve Patient and Family Outcomes in the Intensive Care Unit
Status: Enrolling
Updated: 6/25/2013
Click here to add this to my saved trials
Vibrating, Cold Device for Pediatric Intravenous (IV) Cannulation Pain Relief
Updated: 7/8/2013
Testing the Efficacy of a Vibrating, Cold Device for Pediatric IV Cannulation Pain Relief in the Emergency Department
Status: Enrolling
Updated: 7/8/2013
Vibrating, Cold Device for Pediatric Intravenous (IV) Cannulation Pain Relief
Updated: 7/8/2013
Testing the Efficacy of a Vibrating, Cold Device for Pediatric IV Cannulation Pain Relief in the Emergency Department
Status: Enrolling
Updated: 7/8/2013
Click here to add this to my saved trials
Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism
Updated: 7/12/2013
Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism
Status: Enrolling
Updated: 7/12/2013
Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism
Updated: 7/12/2013
Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism
Status: Enrolling
Updated: 7/12/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Updated: 8/1/2013
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Retraining Attention to Treat Alcohol Dependence and Social Anxiety
Updated: 8/7/2013
Cognitive Bias Modification: A Novel Intervention for Alcohol Dependence and Social Anxiety
Status: Enrolling
Updated: 8/7/2013
Retraining Attention to Treat Alcohol Dependence and Social Anxiety
Updated: 8/7/2013
Cognitive Bias Modification: A Novel Intervention for Alcohol Dependence and Social Anxiety
Status: Enrolling
Updated: 8/7/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder
Updated: 8/26/2013
A Double-blind, Placebo-Controlled Fixed-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 8/26/2013
Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder
Updated: 8/26/2013
A Double-blind, Placebo-Controlled Fixed-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 8/26/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder
Updated: 8/26/2013
A Double-blind, Placebo-Controlled Fixed-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 8/26/2013
Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder
Updated: 8/26/2013
A Double-blind, Placebo-Controlled Fixed-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 8/26/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder
Updated: 8/26/2013
A Double-blind, Placebo-Controlled Fixed-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 8/26/2013
Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder
Updated: 8/26/2013
A Double-blind, Placebo-Controlled Fixed-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 8/26/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder
Updated: 8/26/2013
A Double-blind, Placebo-Controlled Fixed-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 8/26/2013
Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder
Updated: 8/26/2013
A Double-blind, Placebo-Controlled Fixed-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 8/26/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder
Updated: 8/26/2013
A Double-blind, Placebo-Controlled Fixed-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 8/26/2013
Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder
Updated: 8/26/2013
A Double-blind, Placebo-Controlled Fixed-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 8/26/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder
Updated: 8/26/2013
A Double-blind, Placebo-Controlled Fixed-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 8/26/2013
Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder
Updated: 8/26/2013
A Double-blind, Placebo-Controlled Fixed-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 8/26/2013
Click here to add this to my saved trials
Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder
Updated: 8/26/2013
A Double-blind, Placebo-Controlled Fixed-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 8/26/2013
Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder
Updated: 8/26/2013
A Double-blind, Placebo-Controlled Fixed-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 8/26/2013
Click here to add this to my saved trials